Oscar Health, Inc. $OSCR Shares Acquired by Rhumbline Advisers

Key Points

• Rhumbline Advisers increased its holdings in Oscar Health, Inc. by 6.0% during the first quarter, bringing its total ownership to 287,458 shares valued at approximately $3.77 million.
• Several institutional investors, including Vanguard Group and T. Rowe Price, also boosted their stakes in Oscar Health, with a combined institutional ownership of 75.70% of the company's stock.
• Analysts have revised their ratings on Oscar Health, with a consensus average rating of "Strong Sell" and a price target drop to $12.07.

Rhumbline Advisers raised its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 6.0% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 287,458 shares of the company's stock after purchasing an additional 16,231 shares during the period. Rhumbline Advisers owned 0.11% of Oscar Health worth $3,769,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Strs Ohio acquired a new stake in shares of Oscar Health in the 1st quarter worth $30,000. Intech Investment Management LLC increased its holdings in Oscar Health by 50.3% in the first quarter. Intech Investment Management LLC now owns 139,600 shares of the company's stock valued at $1,830,000 after buying an additional 46,748 shares during the last quarter. Focus Partners Wealth grew its holdings in shares of Oscar Health by 1.8% during the first quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock worth $723,000 after purchasing an additional 949 shares during the last quarter. SCS Capital Management LLC acquired a new stake in shares of Oscar Health during the first quarter worth about $131,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Oscar Health by 39.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company's stock valued at $6,169,000 after purchasing an additional 132,149 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Down 0.7%

OSCR stock traded down $0.14 during midday trading on Friday, reaching $18.97. 17,336,897 shares of the company's stock traded hands, compared to its average volume of 16,224,456. The company has a market cap of $4.90 billion, a price-to-earnings ratio of -23.42 and a beta of 1.87. The firm's fifty day moving average price is $16.19 and its 200-day moving average price is $15.27. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. The business had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company's revenue was up 29.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.20 earnings per share. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Robert W. Baird reiterated a "neutral" rating and issued a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Baird R W lowered shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Wells Fargo & Company downgraded shares of Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their target price for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Finally, Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.